Select Medical (NYSE:SEM) Upgraded by StockNews.com to Buy Rating

StockNews.com upgraded shares of Select Medical (NYSE:SEM) from a hold rating to a buy rating in a research report report published on Tuesday morning.

Other equities analysts have also issued research reports about the stock. Royal Bank of Canada lifted their price target on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Bank of America initiated coverage on Select Medical in a report on Tuesday, August 20th. They set a “buy” rating and a $42.00 target price on the stock. Finally, Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th.

Select Medical Trading Down 2.1 %

NYSE SEM opened at $20.59 on Tuesday. Select Medical has a twelve month low of $20.00 and a twelve month high of $40.98. The business’s fifty day moving average is $33.53 and its 200 day moving average is $34.53. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The company has a market cap of $2.67 billion, a price-to-earnings ratio of 9.62, a price-to-earnings-growth ratio of 0.47 and a beta of 1.43.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.07. The company had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.46 earnings per share. As a group, sell-side analysts expect that Select Medical will post 1.74 EPS for the current fiscal year.

Select Medical Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were issued a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.43%. The ex-dividend date was Wednesday, November 13th. Select Medical’s payout ratio is 23.36%.

Insider Activity at Select Medical

In other news, Director Marilyn B. Tavenner sold 32,000 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the sale, the director now directly owns 22,000 shares in the company, valued at $463,980. This trade represents a 59.26 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 17.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Tidal Investments LLC bought a new position in shares of Select Medical in the 1st quarter worth $467,000. Comerica Bank lifted its stake in shares of Select Medical by 30.0% in the first quarter. Comerica Bank now owns 68,485 shares of the health services provider’s stock valued at $2,065,000 after buying an additional 15,824 shares in the last quarter. Boston Partners acquired a new position in shares of Select Medical during the first quarter valued at about $718,000. GAMMA Investing LLC increased its position in shares of Select Medical by 52.8% during the second quarter. GAMMA Investing LLC now owns 1,983 shares of the health services provider’s stock worth $70,000 after acquiring an additional 685 shares in the last quarter. Finally, Linden Thomas Advisory Services LLC lifted its position in Select Medical by 9.2% in the 2nd quarter. Linden Thomas Advisory Services LLC now owns 18,938 shares of the health services provider’s stock valued at $664,000 after acquiring an additional 1,601 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.